Skip to Content

Join the 'Multiple Sclerosis' group to help and get support from people like you.

Multiple Sclerosis News

Related terms: MS

Immune-Based Therapy Shows Early Promise Against MS

Posted 5 days ago by Drugs.com

THURSDAY, April 20, 2017 – An experimental immune-system therapy appears safe for people with progressive forms of multiple sclerosis. And it may ease symptoms in some, a preliminary study suggests. The findings are based on just six patients, and the Australian researchers stressed that a lot of work still lies ahead. But they were encouraged that this new approach to MS had no major side effects. In addition, three of the six patients showed symptom improvements, including reduced fatigue and better mobility. It's not clear, however, what to make of those improvements, said Bruce Bebo, executive vice president of research for the National Multiple Sclerosis Society. The study was a "phase 1" trial, meaning it was designed only to test the therapy's safety. "Based on this very preliminary study, the therapy appears safe," said Bebo, who was not involved in the research. "But I'd be ... Read more

Related support groups: Multiple Sclerosis, Chronic Spasticity, Spasticity, Diagnosis and Investigation, Upper Limb Spasticity, Lower Limb Spasticity, Spinal Spasticity

Ocrevus Approved to Treat Severe Form of Multiple Sclerosis

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – The injected drug Ocrevus (ocrelizumab) has been approved by the U.S. Food and Drug Administration to treat adults with primary progressive multiple sclerosis (PPMS) and relapsing forms of the disease, the agency said Wednesday in a news release. MS is an inflammatory autoimmune disease of the central nervous system, characterized by periods of active symptoms (relapses) and recovery periods (remission). Disrupting communication between the brain and the rest of the body, it's among the most common neurological causes of disability in young adults. More women than men are diagnosed, typically between ages 20 and 40. About 15 percent of people with MS have PPMS, the FDA said, citing the U.S. Centers for Disease Control and Prevention. In clinical trials, upper respiratory infection was the most common side effect of Ocrevus among users with either PPMS or ... Read more

Related support groups: Multiple Sclerosis, Chronic Spasticity, Spasticity, Upper Limb Spasticity, Ocrevus, Spinal Spasticity, Lower Limb Spasticity

FDA-OK'd Drug Offers Hope to Sickest MS Patients

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – A new multiple sclerosis drug approved by the U.S. Food and Drug Administration late Tuesday offers hope to patients with the most severe form of the progressive disease. The intravenous drug, made by Genentech, is called ocrelizumab (Ocrevus). Given every six months, it worked best for patients with relapsing multiple sclerosis (MS) – the most common form of the disease, the FDA reported. But Ocrevus also appeared to slow progression of a more severe type of the disease, called primary progressive MS. "If the side effect profile continues to hold up ... I think ocrelizumab will become the leading MS therapy," said Dr. Steven Galetta, chairman of neurology at NYU Langone Medical Center in New York City. He wasn't involved in the clinical trials that led to the drug's approval. "The drug offers the first option for patients with primary progressive MS," he ... Read more

Related support groups: Multiple Sclerosis, Rebif, Chronic Spasticity, Spasticity, Upper Limb Spasticity, Ocrevus, Lower Limb Spasticity, Spinal Spasticity

FDA Approves Ocrevus (ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis

Posted 29 Mar 2017 by Drugs.com

South San Francisco, CA – March 28, 2017 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) approved Ocrevus (ocrelizumab) as the first and only medicine for both relapsing and primary progressive forms of multiple sclerosis. The majority of people with MS have a relapsing form or primary progressive MS at diagnosis. “The FDA’s approval of Ocrevus is the beginning of a new era for the MS community and represents a significant scientific advance with this first-in-class B cell targeted therapy,” said Sandra Horning, M.D., chief medical officer and head of Global Product Development. “Until now, no FDA-approved treatment has been available to the primary progressive MS community, and some people with relapsing forms of MS continue to experience disease activity and disability progression despite availab ... Read more

Related support groups: Multiple Sclerosis, Ocrevus, Ocrelizumab

Controversial MS Treatment Seems Ineffective

Posted 8 Mar 2017 by Drugs.com

WEDNESDAY, March 8, 2017 – An invasive multiple sclerosis treatment called liberation therapy is not only costly, it's also ineffective, new research contends. Since 2009, thousands of multiple sclerosis (MS) patients have undergone the controversial treatment. Liberation therapy involves opening up narrowed veins from the brain and spinal cord. However, many specialists have had doubts about the success of the procedure, the study authors said in background notes. In this Canadian study, 49 MS patients underwent liberation therapy and 55 other patients received a sham procedure. One year later, brain scans, doctors' reports and patient self-assessments of MS symptoms found no differences between the two groups of patients. "We hope these findings, coming from a carefully controlled, 'gold standard' study, will persuade people with MS not to pursue liberation therapy," said Dr. Anthony ... Read more

Related support groups: Multiple Sclerosis, Autoimmune Disorders, Chronic Spasticity, Caltrate 600 with D, Spasticity, Calcium/Vitamin D, Citracal + D, Upper Limb Spasticity, Citracal Petites, Oysco 500 with D, Lower Limb Spasticity, Calcarb with D, Spinal Spasticity, Oyster Shell Calcium, Citracal Creamy Bites, Calcium 600 D, Calcet, Oystercal-D, Citracal 250 mg + D, Calvite P

Patient Organizations Offer Advice on Reforming Obamacare

Posted 7 Mar 2017 by Drugs.com

MONDAY, March 6, 2017 – The U.S. Congress needs to focus on certain areas as it considers changes to the Affordable Care Act, according to a coalition of 11 major patient groups. "As Congress begins debate on how to improve the nation's health care system, our organizations will evaluate any proposed changes based on a set of Consensus Health Care Reform Principles we believe necessary to provide affordable, accessible and adequate coverage for all Americans," said a March 6 statement from the coalition. The coalition represents millions of patients. These 11 patient groups have banded together to ensure that any changes in the health care law, sometimes called Obamacare, address the concerns of those patients. "First, we believe that any new plan cannot jeopardize the health care coverage Americans currently have through employers, the marketplace, Medicaid or Medicare. They should be ... Read more

Related support groups: Cancer, Multiple Sclerosis, Heart Disease, Cystic Fibrosis, Diabetes Mellitus, Respiratory Tract Disease

FDA Throws Cold Water on Whole Body Cryotherapy

Posted 3 Mar 2017 by Drugs.com

FRIDAY, March 3, 2017 – There's no evidence that a growing trend called whole body cryotherapy is effective, but it does pose a number of risks, the U.S. Food and Drug Administration warns. In whole body cryotherapy, people are placed in an enclosed space and exposed to vapors that reach ultra-low temperatures ranging from minus 200 to minus 300 degrees Fahrenheit, typically for two to four minutes. Many spas and wellness centers claim that whole body cryotherapy can treat diseases and conditions such as Alzheimer's, fibromyalgia, migraines, rheumatoid arthritis, multiple sclerosis, stress, anxiety or chronic pain. "Based on purported health benefits seen in many promotions for cryotherapy spas, consumers may incorrectly believe that the FDA has cleared or approved [whole body cryotherapy] devices as safe and effective to treat medical conditions. That is not the case," Dr. Aron ... Read more

Related support groups: Anxiety, Back Pain, Fibromyalgia, Anxiety and Stress, Rheumatoid Arthritis, Migraine, Multiple Sclerosis, Alzheimer's Disease, Burns - External

Immune Disorders Such as MS, Psoriasis May Be Tied to Dementia Risk

Posted 2 Mar 2017 by Drugs.com

WEDNESDAY, March 1, 2017 – People with autoimmune diseases – conditions that cause a person's immune system to turn against the body – appear to have an increased risk of developing dementia, a new British study suggests. Researchers found that 18 out of 25 different autoimmune diseases, such as lupus, psoriasis or multiple sclerosis, "showed a statistically significant association with dementia," said study co-author Dr. Michael Goldacre. He's a professor of public health at the University of Oxford. But Goldacre and other experts stressed that the study didn't prove that autoimmune diseases cause dementia. The research only showed that these conditions are associated with a higher risk of dementia. Specifically, the study found that people with multiple sclerosis appeared to have nearly double the risk of dementia. Psoriasis was associated with a 29 percent increased risk of ... Read more

Related support groups: Multiple Sclerosis, Heart Disease, Ischemic Stroke, Psoriasis, Dementia, Alzheimer's Disease, Transient Ischemic Attack, Plaque Psoriasis, Ischemic Stroke - Prophylaxis, Chronic Spasticity, Spasticity, Ischemic Heart Disease, Psoriatic Arthropathy

Stem Cell Transplants May Help Some With Multiple Sclerosis

Posted 20 Feb 2017 by Drugs.com

MONDAY, Feb. 20, 2017 – Stem cell transplants may halt the progression of aggressive multiple sclerosis (MS) in nearly half of those with the debilitating disease, but picking the right patients for the treatment is key, a new study suggests. Specifically, younger patients with a relapsing form of MS who were not severely disabled and who hadn't found relief with other treatments fared better than others over five years, the international team of researchers found. However, in some cases the treatment proved fatal, the researchers reported. "Stem cell transplantation cannot be considered a cure for MS. However, it can be considered a concrete option for patients showing aggressive MS who have not responded to approved treatments," said study co-author Dr. Riccardo Saccardi. He's from the cell therapy and transfusion medicine unit at Careggi University Hospital in Florence, Italy. Using ... Read more

Related support groups: Multiple Sclerosis, Chronic Spasticity, Spasticity, Diagnosis and Investigation, Upper Limb Spasticity, Lower Limb Spasticity, Spinal Spasticity

U.S. Report Cites the Good and Bad on Marijuana

Posted 12 Jan 2017 by Drugs.com

THURSDAY, Jan. 12, 2017 – Current medical science has proven there are legitimate medical uses for marijuana and cannabis-derived drugs, a new report from the National Academy of Sciences states. Conclusive or substantial scientific evidence has shown that marijuana products are effective at treating chronic pain, calming muscle spasms caused by multiple sclerosis, and easing nausea from chemotherapy, the report said. However, there's little to no evidence supporting any of the other numerous health claims related to marijuana, the report said. And there's a downside as well – marijuana use comes with a host of potential health risks, whether someone is using the drug medicinally or recreationally, according to the report. The report calls on government to ease regulations that hamper research into marijuana, so scientists can sort the wheat from the chaff when it comes to medical ... Read more

Related support groups: Pain, Anxiety, Anxiety and Stress, Chronic Pain, Muscle Spasm, Muscle Pain, Social Anxiety Disorder, Multiple Sclerosis, Schizophrenia, Breakthrough Pain, Schizoaffective Disorder, Chronic Spasticity, Cannabis, Spasticity, Lower Limb Spasticity, Spinal Spasticity

New MS Drug Shows 'Breakthrough' Promise for Advanced Disease

Posted 22 Dec 2016 by Drugs.com

THURSDAY, Dec. 22, 2016 – A new drug slows the progress of multiple sclerosis, including an advanced form of the degenerative nerve disease for which there currently is no treatment, according to a pair of new clinical trials. One MS specialist called the intravenous drug, ocrelizumab, a "breakthrough." Ocrelizumab reduced the advance of MS-related disability by 24 percent in people with primary progressive MS compared to a placebo, results from one clinical trial show. Researchers compared ocrelizumab against a placebo, or dummy drug, because there's no approved treatment available for primary progressive MS. This form affects about 15 percent of MS patients, said Dr. Stephen Hauser, chair of neurology at the University of California, San Francisco. "It does represent new hope for people with progressive MS," said Hauser, who worked on both reports. Ocrelizumab also proved superior in ... Read more

Related support groups: Multiple Sclerosis, Chronic Spasticity, Spasticity, Upper Limb Spasticity, Spinal Spasticity, Lower Limb Spasticity

Could Low Vitamin D Levels at Birth Mean Higher MS Risk?

Posted 2 Dec 2016 by Drugs.com

THURSDAY, Dec. 1, 2016 – Newborns with low levels of vitamin D may have higher odds of developing multiple sclerosis (MS) later in life, new research suggests. Vitamin D deficiency is common among the general population, including pregnant women. But the researchers said it's too soon to routinely recommend "sunshine vitamin" supplements for mothers-to-be. "The study does not prove that increasing vitamin D levels reduces the risk of MS. Further studies are needed to confirm our results," said study leader Dr. Nete Munk Nielsen, a researcher at the Statens Serum Institute in Copenhagen, Denmark. About 2.5 million people worldwide have MS. It's a chronic disease of the central nervous system characterized by damage to myelin, the fatty substance coating nerve fibers. MS symptoms vary, but can include walking difficulties, fatigue, numbness and vision problems. A growing body of evidence ... Read more

Related support groups: Multiple Sclerosis, Vitamin D Deficiency, Vitamin/Mineral Supplementation and Deficiency, Delivery, Chronic Spasticity, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Caltrate 600 with D, Spasticity, Vitamin D Insufficiency, Upper Limb Spasticity, Citracal + D, Calcium/Vitamin D, Citracal Petites, Oysco 500 with D, Calcium 600 D, Calcarb with D, Labor and Delivery including Augmentation, Lower Limb Spasticity, Spinal Spasticity, Oyster Shell Calcium

MS Symptoms May Develop Earlier in Darker, Cooler Climes

Posted 4 Nov 2016 by Drugs.com

THURSDAY, Nov. 3, 2016 – The farther from the Equator someone with multiple sclerosis lives, the earlier symptoms begin, a new study finds. MS is a progressive disease affecting the central nervous system. Although symptoms vary, they often include fatigue, dizziness, weakness, numbness or tingling, trouble walking and vision problems. The cause of MS is thought to be an interplay of genetic and environmental factors, including latitude and/or exposure to sunlight and vitamin D levels. But it wasn't known if latitude – the distance north or south of the Equator – affected the age when symptoms start. To examine the issue, Dr. Bruce Taylor, a professor at Menzies Institute for Medical Research at the University of Tasmania, and colleagues analyzed data from more than 22,000 MS patients in Australia and 20 countries in Europe, North and South America and Asia. According to the new ... Read more

Related support groups: Multiple Sclerosis, Chronic Spasticity, Spasticity, Upper Limb Spasticity, Spinal Spasticity, Lower Limb Spasticity

Powerful MS Drug Used Early May Reverse Some Disability

Posted 14 Oct 2016 by Drugs.com

FRIDAY, Oct. 14, 2016 – A multiple sclerosis drug usually reserved for people in the late stages of the disease seems to offer long-term remission in newly diagnosed patients, researchers report. Because of serious side effects, the drug – Lemtrada (alemtuzumab) – is approved in the United States only for patients who have failed other treatments. But the authors of a new study believe giving it early may slow and even reverse some disease-related disability. "The expectation in MS has always been to try to slow down the progression of the disease. Now we can tell our patients that a significant number can actually improve by reversing their disability," said lead researcher Dr. Gavin Giovannoni. He is a neurology professor at Queen Mary University of London in England. The treatment is not without its downsides, however. Because of the potential for side effects, people who received ... Read more

Related support groups: Multiple Sclerosis, Chronic Spasticity, Spasticity, Upper Limb Spasticity, Lemtrada, Campath, Spinal Spasticity, Lower Limb Spasticity, Alemtuzumab

Exercise May Not Lower Women's Risk of Multiple Sclerosis

Posted 29 Sep 2016 by Drugs.com

THURSDAY, Sept. 29, 2016 – Regular workouts may cut a woman's chances for heart disease and certain cancers, but new research suggests they won't lower the risk of multiple sclerosis (MS). The new study "did not provide evidence to support" the notion that exercise lowers MS risk, said study author Kassandra Munger, of the Harvard School of Public Health in Boston. For the study, Munger's group tracked data on more than 193,000 American women involved in the Nurses' Health Study and Nurses' Health Study 2. These women were followed for up to 20 years. They had to fill out questionnaires regarding their current physical activity as well as the exercise they got when they were growing up. Munger's team used this information to calculate the number of hours the women exercised each week. Over the course of the study, 341 of the women were diagnosed with MS. After considering a number of ... Read more

Related support groups: Cancer, Multiple Sclerosis, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Spasticity, Central Nervous System Disorders

Related Drug Support Groups

prednisone, prednisolone, dexamethasone, Gilenya, Tysabri, valacyclovir, Copaxone, Imuran, Decadron, view more... Ampyra, Avonex, azathioprine, Tecfidera, Rebif, mycophenolate mofetil, Aubagio, Orapred, cyclophosphamide, Betaseron, Acthar, Prelone, Acthar Gel, HP, Acth, cladribine, Deltasone, fingolimod, interferon beta-1a, glatiramer, Plegridy, Lemtrada, natalizumab, Azasan, Ocrevus, Predalone 50, dalfampridine, Dexone, dimethyl fumarate, Veripred 20, PediaPred, Extavia, alemtuzumab, Avonex Prefilled Syringe, Adrenocot LA, Orapred ODT, Sterapred, Dexpak Taperpak, Adrenocot, interferon beta-1b, Sterapred DS, Zinbryta, Glatopa, corticotropin, Liquid Pred, Delta-Cortef, Prednicot, Flo-Pred, Prednicen-M, Orasone, Decaject LA, Zema Pak, Decaject, AsmalPred Plus, Rebif Rebidose, Avonex Pen, Dalalone LA, Dalalone DP, Dexamethasone Intensol, Millipred DP, Baycadron, Dalalone, Millipred, Decadron-LA, Predacort 50, Predicort-50, Cotolone, Predate-50, Predaject-50, Key-Pred SP, Pred-Ject-50, Key-Pred, Hydeltrasol, teriflunomide, mitoxantrone, daclizumab, peginterferon beta-1a, ocrelizumab, Hydeltra-TBA, Novantrone, Medicort, Predicort RP, Dexone LA, Dexasone LA, Dexasone, Primethasone, Dexacorten, Medidex LA, Medidex, Dexacort-LA, De-Sone LA, Bubbli-Pred, Predcor, Pri-Cortin 50, Hexadrol, Solurex LA, Solurex, Dexacen-4, Meticorten